Skip to main content

Vaginal Adenosquamous Carcinoma clinical trials at UC Health
1 research study open to new patients

  • Standard of Care Treatment for Newly Diagnosed Cervical or Vaginal Cancer With or Without Triapine

    “You are being asked to take part in this study because you have newly-diagnosed cervical or vaginal cancer that cannot be operated on.”

    open to eligible females ages 18 years and up

    This randomized phase II trial studies radiation therapy and cisplatin with triapine to see how well they work compared to the standard radiation therapy and cisplatin alone in treating patients with newly diagnosed stage IB2, II, or IIIB-IVA cervical cancer or stage II-IVA vaginal cancer. Radiation therapy uses high energy protons to kill tumor cells and shrink tumors. Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Triapine may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether radiation therapy and cisplatin are more effective with triapine in treating cervical or vaginal cancer.

    at UCSD UC Davis

Last updated: